Information Provided By: 
Fly News Breaks for August 20, 2018
ISR
Aug 20, 2018 | 10:18 EDT
H.C. Wainwright analyst Jason Kolbert started IsoRay with a Neutral rating and $1.00 price target, stating that GammaTile, an innovative collagen wafer embedded with Cs-131 seeds for the treatment of recurrent brain tumors, has the potential to become an important new source of revenue, but he is taking a wait-and-see approach until the revenue prospects become more visible.
News For ISR From the Last 2 Days
There are no results for your query ISR
